Galderma will present two late-breaking presentations on clinical trials evaluating the long-term efficacy of the investigational monoclonal antibody nemolizumab in prurigo nodularis and its durabil......
Galderma will present two late-breaking presentations on clinical trials evaluating the long-term efficacy of the investigational monoclonal antibody nemolizumab in prurigo nodularis and its durabil......
SES’s Managed Enterprise service will enable INRED to connect thousands of remote sites across Colombia to support the Ministry of Information and Communication Technologies’ digital inclu......
